These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 17210147

  • 1. Expression of S100 protein and protective effect of arundic acid on the rat brain in chronic cerebral hypoperfusion.
    Ohtani R, Tomimoto H, Wakita H, Kitaguchi H, Nakaji K, Takahashi R.
    Brain Res; 2007 Mar 02; 1135(1):195-200. PubMed ID: 17210147
    [Abstract] [Full Text] [Related]

  • 2. Modulation of astrocytic activation by arundic acid (ONO-2506) mitigates detrimental effects of the apolipoprotein E4 isoform after permanent focal ischemia in apolipoprotein E knock-in mice.
    Mori T, Town T, Tan J, Tateishi N, Asano T.
    J Cereb Blood Flow Metab; 2005 Jun 02; 25(6):748-62. PubMed ID: 15689951
    [Abstract] [Full Text] [Related]

  • 3. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H, Kurosaki R, Oki C, Araki T.
    Brain Res; 2004 Dec 24; 1030(1):66-73. PubMed ID: 15567338
    [Abstract] [Full Text] [Related]

  • 4. Is endothelial dysfunction of cerebral small vessel responsible for white matter lesions after chronic cerebral hypoperfusion in rats?
    Huang Y, Zhang W, Lin L, Feng J, Chen F, Wei W, Zhao X, Guo W, Li J, Yin W, Li L.
    J Neurol Sci; 2010 Dec 15; 299(1-2):72-80. PubMed ID: 20850139
    [Abstract] [Full Text] [Related]

  • 5. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat.
    Tomimoto H, Ihara M, Wakita H, Ohtani R, Lin JX, Akiguchi I, Kinoshita M, Shibasaki H.
    Acta Neuropathol; 2003 Dec 15; 106(6):527-34. PubMed ID: 13680276
    [Abstract] [Full Text] [Related]

  • 6. [White matter lesions after occlusion of the bilateral carotid arteries in the rat--temporal profile of cerebral blood flow (CBF), oligodendroglia and myelin].
    Tomimoto H, Akiguchi I, Wakita H, Kimura J.
    No To Shinkei; 1997 Jul 15; 49(7):639-44. PubMed ID: 9234252
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of suppression of astrocytic activation by arundic acid on brain injuries in rats with acute subdural hematomas.
    Wajima D, Nakagawa I, Nakase H, Yonezawa T.
    Brain Res; 2013 Jun 26; 1519():127-35. PubMed ID: 23685194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits.
    Tateishi N, Mori T, Kagamiishi Y, Satoh S, Katsube N, Morikawa E, Morimoto T, Matsui T, Asano T.
    J Cereb Blood Flow Metab; 2002 Jun 26; 22(6):723-34. PubMed ID: 12045671
    [Abstract] [Full Text] [Related]

  • 11. The effect of pre- and posttreatment with diazoxide on the early phase of chronic cerebral hypoperfusion in the rat.
    Farkas E, Institóris A, Domoki F, Mihály A, Bari F.
    Brain Res; 2006 May 04; 1087(1):168-74. PubMed ID: 16624259
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion.
    Lee JH, Park SY, Shin YW, Hong KW, Kim CD, Sung SM, Kim KY, Lee WS.
    Brain Res; 2006 Apr 12; 1082(1):182-91. PubMed ID: 16516167
    [Abstract] [Full Text] [Related]

  • 14. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y, Zhang N, Miyamoto N, Tanaka R, Hattori N, Urabe T.
    Neuroscience; 2009 Aug 18; 162(2):317-27. PubMed ID: 19409967
    [Abstract] [Full Text] [Related]

  • 15. Chronic cerebral hypoperfusion-induced neuropathological changes in rats.
    Nanri M, Miyake H, Murakami Y, Matsumoto K, Watanabe H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Oct 18; 18(5):181-8. PubMed ID: 10028489
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia.
    Ohtani R, Tomimoto H, Kondo T, Wakita H, Akiguchi I, Shibasaki H, Okazaki T.
    Brain Res; 2004 Oct 08; 1023(1):31-40. PubMed ID: 15364016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion.
    Cai QY, Chen XS, Zhan XL, Yao ZX.
    Neurosci Lett; 2011 Jun 15; 497(1):22-6. PubMed ID: 21524686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.